Plain-English translation of NCT07171216 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When your kidneys don't work well, they can't control parathyroid hormone (PTH) levels properly, which weakens your bones and increases your risk of fractures. This trial compares two different treatment strategies using medications like activated vitamin D, phosphate binders, native vitamin D, and Cinacalcet to see which approach better protects your bones. One group will start treatment as soon as PTH rises above normal, while the other will wait until PTH becomes very high.
Doctors aren't sure which approach—treating PTH aggressively early or waiting until it becomes very high—better protects bone health in people with advanced kidney disease. This trial will help answer that question and guide future treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two treatment groups and take medications to manage your parathyroid hormone levels according to your group's strategy. Your doctors will monitor your PTH levels regularly and adjust your medications as needed. The study will track changes in your bone density using special X-ray scans (called DXA scans) to see how well each treatment approach protects your bones over time.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
Denmark